Trials / Conditions / Stage 5 Chronic Kidney Disease
Stage 5 Chronic Kidney Disease
5 registered clinical trials studyying Stage 5 Chronic Kidney Disease.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI NCT03602261 | OPKO Health, Inc. | Phase 2 |
| Completed | Risk of Falling in Chronic Kidney Disease 5 NCT02392299 | Queen Margaret University | — |
| Completed | Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5 NCT02392208 | University of Michigan | Phase 4 |
| Unknown | Comparison of Outcomes Between Hemodialysis and Peritoneal Dialysis Patients in a Multi-Ethnic Asian Populatio NCT01587443 | National University of Singapore | — |
| Unknown | Impact of a Multidisciplinary Intensive Management Clinic on Outcomes in Multi-Ethnic Asian Incident Hemodialy NCT01509690 | National University of Singapore | Phase 2 / Phase 3 |